Futibatinib (Lytgobi): Uses in Cancer, Side Effects, Dosage, Expectations, and More - OncoDaily Futibatinib (Lytgobi) is FGFR inhibitor, which used in treatment of cholangiocarcinoma. Learn more about its uses, side effects, dosage, expectation.

Futibatinib (Lytgobi): Uses in Cancer, Side Effects, Dosage, Expectations, and More

oncodaily.com/drugs/futiba...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Futibatinib #Lytgobi #BileDuctCancer #IntrahepaticCholangiocarcinoma #iCCA

@US_FDA approves #Futibatinib for FGFR2+ Advanced #CCA. It’s been a great 2 years for BTC survivors with addition of #durvalumab + gem/cis as well as #ivosidenib (IDH1) #infigratinib #pemigatinib (FGFR2 fusion) #dabrafenib #trametinib (BRAF V600E)